Target
Egl nine homolog 1 [182-426]
Ligand
BDBM373673
Substrate
n/a
Meas. Tech.
PHD enzymatic assay
IC50
39.8±n/a nM
Citation
 Rabinowitz, MHRosen, MDTarantino, KTVenkatesan, H 4-Aminoquinazolin compounds as prolyl hydroxylase inhibitors US Patent  US10246442 Publication Date 4/2/2019 
Target
Name:
Egl nine homolog 1 [182-426]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | HIF-1alpha-PHD2
Type:
Enzyme Catalytic Domain
Mol. Mass.:
27392.37
Organism:
Homo sapiens (Human)
Description:
Q9GZT9[182-426]
Residue:
245
Sequence:
NGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF
  
Inhibitor
Name:
BDBM373673
Synonyms:
1-(4-(Dimethylamino)-7-chloro-6-isopropylquinazolin-2-yl)-1H-pyrazole-4-carboxylic acid; | US10246442, Example 161 | US10975062, Example 161
Type:
Small organic molecule
Emp. Form.:
C17H18ClN5O2
Mol. Mass.:
359.81
SMILES:
CC(C)c1cc2c(nc(nc2cc1Cl)-n1cc(cn1)C(O)=O)N(C)C
Structure:
Search PDB for entries with ligand similarity: